A carregar...

Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma

PURPOSE: Minimal residual disease (MRD) presents a significant hurdle to curing metastatic neuroblastoma (NB). Biologic therapies directed against MRD can improve outcome. Evaluating treatment efficacy requires MRD measurement, which serves as surrogate endpoint. Because of tumor heterogeneity, no s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cheung, Irene Y., Feng, Yi, Gerald, William, Cheung, Nai-Kong V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670609/
https://ncbi.nlm.nih.gov/pubmed/18980998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!